Abstract
Idiopathic normal pressure hydrocephalus (iNPH) is a disabling neurological disorder whose potential treatability is significantly limited by diagnostic uncertainty. In fact, typical clinical presentation occurs at late phases of disease, when CSF shunting could be ineffective. In recent years, measurement of different CSF proteins, whose concentration directly reflects neuropathological changes of CNS, has significantly improved both diagnostic timing and accuracy of neurodegenerative disease. Unfortunately iNPH lacks neuropathological hallmarks allowing the identification of specific disease biomarkers. However, neuropathology of iNPH is so rich and heterogeneous that many processes can be tracked in CSF, including Alzheimer’s disease core pathology, subcortical degeneration, neuroinflammation and vascular dysfunction. Indeed, a huge number of CSF biomarkers have been analyzed in iNPH patients, but a unifying profile has not been provided yet. In this brief survey, we thus attempted to summarize the main findings in the field of iNPH CSF biomarkers, aimed at outlining a synthetic model. Although defined cut-off values for biomarkers are not available, a better knowledge of CSF characteristics may definitely assist in diagnosing the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ågren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, Bergenheim AT, Malm J (2007) CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand 116(5):333–339. https://doi.org/10.1111/j.1600-0404.2007.00890.x
Bech-Azeddine R, Høgh P, Juhler M, Gjerris F, Waldemar G (2007) Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry 78(2):157–161. https://doi.org/10.1136/jnnp.2006.095117
Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Publ Group 6(3):131–144
Blennow K, Biscetti L, Eusebi P, Parnetti L (2016) Cerebrospinal fluid biomarkers in Alzheimer’s and parkinson’s diseases-from pathophysiology to clinical practice. Mov Disord 31(6):836–847. https://doi.org/10.1002/mds.26656
Bradley WG (2015) CSF flow in the brain in the context of normal pressure hydrocephalus. Am J Neuroradiol 36(5):831–838. https://doi.org/10.3174/ajnr.A4124
Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, Sabbagh MN (2011) Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimer’s Dement 7(5):509–513. https://doi.org/10.1016/j.jalz.2010.12.008
Castañeyra-Ruiz L, González-Marrero I, Carmona-Calero EM, Abreu-Gonzalez P, Lecuona M, Brage L, Rodríguez EM, Castañeyra-Perdomo A (2016) Cerebrospinal fluid levels of tumor necrosis factor alpha and aquaporin 1 in patients with mild cognitive impairment and idiopathic normal pressure hydrocephalus. Clin Neurol Neurosurg 146(July):76–81. https://doi.org/10.1016/j.clineuro.2016.04.025
Chow BW, Chenghua G (2015) The molecular constituents of the blood–brain barrier. Trends Neurosci 38(10):598–608. https://doi.org/10.1016/j.tins.2015.08.003
Ghosh S, Lippa C (2014) Diagnosis and prognosis in idiopathic normal pressure hydrocephalus. Am J Alzheimer’s Dis Other Dement 29(7):583–589. https://doi.org/10.1177/1533317514523485
Graff-Radford NR (2014) Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology 83(17):1573–1575. https://doi.org/10.1212/WNL.0000000000000916
Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2(4):307–327
Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM et al (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68(4):535–540. https://doi.org/10.1002/ana.22015
Hamlat A, Adn M, Sid-ahmed S, Askar B, Pasqualini E (2006) Theoretical considerations on the pathophysiology of normal pressure hydrocephalus (NPH) and NPH-related dementia. Med Hypotheses 67(1):115–123. https://doi.org/10.1016/j.mehy.2006.01.029
Huang H, Yang J, Luciano M, Shriver LP (2016) Longitudinal metabolite profiling of cerebrospinal fluid in normal pressure hydrocephalus links brain metabolism with exercise-induced VEGF production and clinical outcome. Neurochem Res 41(7):1713–1722. https://doi.org/10.1007/s11064-016-1887-z
Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid. Sci Transl Med 4(147):147ra111. https://doi.org/10.1126/scitranslmed.3003748
Israelsson H, Carlberg B, Wikkels C, Laurell K, Kahlon B, Leijon G, Eklund A, Malm J (2017) Vascular risk factors in INPH. Neurology 88(6):577–585. https://doi.org/10.1212/WNL.0000000000003583
Janelidze S, Hertze J, Nägga K, Nilsson K, Nilsson C, Wennström M, van Westen D et al (2017) Increased blood–brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiol Aging 51:104–112. https://doi.org/10.1016/j.neurobiolaging.2016.11.017
Jang H, Park SB, Kim Y, Kim KW, Lee JI, Kim ST, Lee KH et al (2017) Prognostic value of amyloid PET scan in normal pressure hydrocephalus. J Neurol. https://doi.org/10.1007/s00415-017-8650-5
Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkelso C (2014) Prevalence of idiopathic normal-pressure hydrocephalus. Neurology 82(16):1449–1454. https://doi.org/10.1212/WNL.0000000000000342
Jeppsson A, Zetterberg H, Blennow K, Wikkelsø C (2013) Idiopathic normal-pressure hydrocephalus pathophysiology and diagnosis by CSF biomarkers. Neurology 80(15):1385–1392. https://doi.org/10.1212/WNL.0b013e31828c2fda
Jeppsson A, Höltta M, Zetterberg H, Blennow K, Wikkelsø C, Tullberg M (2016) Amyloid Mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids and Barriers of the CNS. BioMed Central 1:1–7. https://doi.org/10.1186/s12987-016-0037-y
Jessen NA, Munk ASF, Lundgaard I, Nedergaard M (2015) The glymphatic system: a beginner’s guide. Neurochem Res 40(12):2583–2599. https://doi.org/10.1007/s11064-015-1581-6
Jingami N, Asada-Utsugi M, Uemura K, Noto R, Takahashi M, Ozaki A, Kihara T et al (2015) Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer’s disease. J Alzheimer’s Dis 45(1):109–115. https://doi.org/10.3233/JAD-142622
Kapaki EN, Paraskevas GP, Tzerakis NG, Sfagos C, Seretis A, Kararizou E, Vassilopoulos D (2007) Cerebrospinal fluid Tau, phospho-Tau 181 and β-amyloid 1–42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer’s disease. Eur J Neurol 14(2):168–173. https://doi.org/10.1111/j.1468-1331.2006.01593.x
Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10(9):698–712. https://doi.org/10.1038/nrd3505
Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, Zaheer S, Iyer SS, Zaheer A (2016) Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine 1(1):1003
Kester MI, Teunissen CE, Sutphen C, Herries EM, Ladenson JH, Xiong C, Scheltens P et al (2015) Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort. Alzheimer’s Res Ther 7(1):59. https://doi.org/10.1186/s13195-015-0142-1
Klassen BT (2011) Normal pressure hydrocephalus how often does the diagnosis hold water ? Neurology 77:1119–1125
Lamers KJB, Vos P, Verbeek MM, Rosmalen F, van Geel WJA, van Engelen BGM (2003) Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull 61(3):261–264. https://doi.org/10.1016/S0361-9230(03)00089-3
Leinonen V, Menon LG, Carroll RS, Dello Iacono D, Grevet J, Jääskeläinen JE, Black PM (2011) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimer’s Dis 2011:312526. https://doi.org/10.4061/2011/312526
Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Sutela A, Vanninen R, Jääskeläinen JE, Soininen H, Alafuzoff I (2012) Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 38(1):72–86. https://doi.org/10.1111/j.1365-2990.2011.01195.x
Li X, Miyajima M, Mineki R, Taka H, Murayama K, Arai H (2006) Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics. Acta Neurochir 148(8):859–864. https://doi.org/10.1007/s00701-006-0787-4
Li X, Miyajima M, Jiang C, Arai H (2007) Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett 413(2):141–144. https://doi.org/10.1016/j.neulet.2006.11.039
Luikku AJ, Hall A, Nerg O, Koivisto AM, Hiltunen M, Helisalmi S, Herukka S-K et al (2016) Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus. Acta Neurochir 158(12):2311–2319. https://doi.org/10.1007/s00701-016-2980-4
Magdalinou N, Lees AJ, Zetterberg H (2014) Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry 85(10):1065–1075. https://doi.org/10.1136/jnnp-2013-307539
Martín-Láez R, Caballero-Arzapalo H, López-Menéndez LÁ, Arango-Lasprilla JC, Vázquez-Barquero A (2015) Epidemiology of idiopathic normal pressure hydrocephalus: a systematic review of the literature. World Neurosurg 84(6):2002–2009. https://doi.org/10.1016/j.wneu.2015.07.005
Mihalj M, Dolić K, Kolić K, Ledenko V (2016) CSF tap test—obsolete or appropriate test for predicting shunt responsiveness? A systemic review. J Neurol Sci 362(March):78–84. https://doi.org/10.1016/j.jns.2016.01.028
Miskin N, Patel H, Franceschi AM, Ades-Aron B, Le A, Damadian BE, Stanton C et al (2017) Diagnosis of normal-pressure hydrocephalus: use of traditional measures in the era of volumetric MR imaging. Radiology. https://doi.org/10.1148/radiol.2017161216
Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, Arai H (2013a) Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol 20(2):236–242. https://doi.org/10.1111/j.1468-1331.2012.03781.x
Miyajima M, Nakajima M, Motoi Y, Moriya M, Sugano H, Ogino I, Nakamura E et al (2013b) Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. Edited by Riqiang Yan. PLoS One 8(9):e74453. https://doi.org/10.1371/journal.pone.0074453
Momjian S (2004) Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 127(5):965–972. https://doi.org/10.1093/brain/awh131
Nakajima M, Miyajima M, Ogino I, Watanabe M, Miyata H, Karagiozov KL, Arai H et al (2011) Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus. Acta Neurochir. https://doi.org/10.1007/s00701-011-0963-z
Nakajima M, Miyajima M, Ogino I, Watanabe M, Hagiwara Y, Segawa T, Kobayashi K, Arai H (2012) Brain localization of leucine-rich α2-glycoprotein and its role. In Acta Neurochir Suppl 113:97–101. https://doi.org/10.1007/978-3-7091-0923-6_20
Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, Ishii K, Kaijima M, Hirata Y, Saito M, Arai H, Japanese Society of Normal Pressure Hydrocephalus (2012) Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) 52(11):775–809
Pfanner T, Henri-Bhargava A, Borchert S (2017) Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus: a systematic review. Can J Neurol Sci. https://doi.org/10.1017/cjn.2017.251
Picascia M, Zangaglia R, Bernini S, Minafra B, Sinforiani E, Pacchetti C (2015) A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus. Funct Neurol 30(4):217–228
Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D, Pisani A (2012) Increased blood–cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease. J Neuroinflamm 9(1):670. https://doi.org/10.1186/1742-2094-9-188
Pyykkö OT, Lumela M, Rummukainen J, Nerg O, Seppälä TT, Herukka S-K, Koivisto AM et al (2014) Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. Edited by Massimo S. Fiandaca. PLoS ONE 9(3):e91974. https://doi.org/10.1371/journal.pone.0091974
Qvarlander S, Lundkvist B, Koskinen L-OD, Malm J, Eklund A (2013) Pulsatility in CSF dynamics: pathophysiology of idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 84(7):735–741. https://doi.org/10.1136/jnnp-2012-302924
Ray B, Reyes PF, Lahiri DK (2011) Biochemical studies in normal pressure hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau. J Psychiatr Res 45(4):539–547. https://doi.org/10.1016/j.jpsychires.2010.07.011
Ringstad G, Vatnehol SAS, Eide PK (2017) Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 140(10):2691–2705. https://doi.org/10.1093/brain/awx191
Rossi S, Motta C, Studer V, Barbieri F, Buttari F, Bergami A, Sancesario G et al (2014) Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler J 20(3):304–312. https://doi.org/10.1177/1352458513498128
Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer’s disease. Lancet. https://doi.org/10.1016/S0140-6736(15)01124-1
Schirinzi T, Sancesario GM, Ialongo C, Imbriani P, Madeo G, Toniolo S, Martorana A, Pisani A (2015) A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus. Front Neurol 6:86. https://doi.org/10.3389/fneur.2015.00086
Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2(8):506–511. https://doi.org/10.1016/S1474-4422(03)00487-3
Simon MJ, Iliff JJ (2016) Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. Biochim Biophys Acta 1862(3):442–451. https://doi.org/10.1016/j.bbadis.2015.10.014
Sosvorova L, Vcelak J, Mohapl M, Vitku J, Bicikova M, Hampl R (2014) Cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuro Endocrinol Lett 35(7):586–593
Sosvorova L, Mohapl M, Vcelak J, Hill M, Vitku J, Hampl R (2015) The impact of selected cytokines in the follow-up of normal pressure hydrocephalus. Physiol Res 64:S283–S290
Sutton LN, Wood JH, Brooks BR, Barrer SJ, Kline M, Cohen SR (1983) Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg 59(3):467–470. https://doi.org/10.3171/jns.1983.59.3.0467
Tarkowski E, Tullberg M, Fredman P, Wikkelsö C (2003) Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging 24(5):707–714
Tarnaris A, Toma AK, Pullen E, Chapman MD, Petzold A, Cipolotti L, Kitchen ND, Keir G, Lemieux L, Watkins LD (2011) Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus. Alzheimer’s Dement 7(5):501–508. https://doi.org/10.1016/j.jalz.2011.01.003
Tsai A, Malek-Ahmadi M, Kahlon V, Sabbagh MN (2014) Differences in cerebrospinal fluid biomarkers between clinically diagnosed idiopathic normal pressure hydrocephalus and Alzheimer’s disease. J Alzheimer’s Dis Parkinsonism. https://doi.org/10.4172/2161-0460.1000150
Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C (1998) CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 50(4):1122–1127
Tullberg M, Blennow K, Månsson J-E, Fredman P, Tisell M, Wikkelsö C (2007) Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur J Neurol 14(3):248–254. https://doi.org/10.1111/j.1468-1331.2006.01553.x
Tullberg M, Blennow K, Månsson J-E, Fredman P, Tisell M, Wikkelsö C (2008) Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res 5(1):9. https://doi.org/10.1186/1743-8454-5-9
Williams MA, Malm J (2016) Diagnosis and treatment of idiopathic normal pressure hydrocephalus. Continuum 22(2):579–599. https://doi.org/10.1212/CON.0000000000000305
Zhang X, Huang W-J, Chen W-W (2016) TGF-β1 factor in the cerebrovascular diseases of Alzheimer’s disease. Eur Rev Med Pharmacol Sci 20(24):5178–5185
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interests. No funding has been received for this study.
Ethical standards
The study was conducted according to ethical principles of Helsinki declaration.
Rights and permissions
About this article
Cite this article
Schirinzi, T., Sancesario, G.M., Di Lazzaro, G. et al. Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus. J Neural Transm 125, 673–679 (2018). https://doi.org/10.1007/s00702-018-1842-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-018-1842-z